🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with locally advanced resectable adenocarcinoma of the stomach or ...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2010-08
Trial ID
NCT01216644
Treatments Being Tested
SMARCA4 mutation is clinically known to be an independent poor prognostic f...
Status
Not Yet Recruiting
Location
The 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou, Fujian, China, 350025
Start Date
2025-08-20
Trial ID
NCT07093762
Treatments Being Tested
To investigate the safety and efficacy of low-dose radiotherapy combined wi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-30
Trial ID
NCT07028918
The purpose of this study is to determine whether primary radiotherapy can ...
Status
Suspended
Location
Union Hospital Fujian Medical University
Start Date
2015-10
Trial ID
NCT02121405
Treatments Being Tested
A prospective, nationwide, implementation program of the international stan...
Status
Recruiting
Location
Amsterdam UMC, locatie AMC
Start Date
2021-07-01
Trial ID
NCT05524090
Treatments Being Tested
Participants in this study have a type of cancer called squamous cell carci...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill
Start Date
2017-12-19
Trial ID
NCT03174275
Treatments Being Tested
This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate t...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2023-06-28
Trial ID
NCT05785728
Treatments Being Tested
This study aims to evaluate the efficacy and safety of JSKN016 combined wit...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2026-03
Trial ID
NCT07493980
Treatments Being Tested
The goal of this prospective, single-center, multi-cohort clinical trial is...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-20
Trial ID
NCT07549906
Treatments Being Tested
ARTemIS-Eso is a phase I-II, three-level, open-label trial with a dose-expa...
Status
Withdrawn
Location
Institut Jules Bordet
Start Date
2017-07-20
Trial ID
NCT03307941
Treatments Being Tested